MINNEAPOLIS, MN, United States, via ETELIGIS INC., 01/16/2015 – – Minnesota based Skyline Medical Inc. (OTCQB: SKLN), announced the sale of a STREAMWAY System to Penn State Milton S. Hershey Medical Center, an academic health center in central Pennsylvania. The unit is for placement in Radiology Biopsy Services with a central focus on thoracentesis and paracentesis procedures in addition to fine needle aspirations and biopsies.
Annually the Medical Center admits more than 29,000 patients, accepts more than 911,000 outpatient visits, receives nearly 67,000 emergency room patients and performs more than 29,000 surgical procedures. Skyline’s STREAMWAY System is used in ultrasound suites as a cost saving, safe method to manage waste fluid.
CEO Josh Kornberg stated, “We are thrilled to see STREAMWAY System selected for the Penn State Hershey’s interventional radiology department. Both the operation theatres and the ultrasound suites typically use glass evacuation bottles and plastic canisters for fluid collection and disposal. These types of procedures use a very high number of canisters which, as well as being costly, can also leave medical staff exposed to infectious waste. By switching to the STREAMWAY System, medical centers are disposing of surgical waste much more safely and efficiently.”
“We are excited to see large hospitals like Penn State Hershey recognize the benefits of the STREAMWAY System and are delighted to have Penn State Hershey as our latest customer,” Kornberg concluded.
About Skyline Medical Inc.:
Skyline Medical Inc. produces a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today’s manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and is not an optimal approach to the handling of surgical fluid waste. Skyline Medical’s STREAMWAY(TM) System fully automates the collection, measurement and disposal of surgical fluids and is designed to result in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies’ safety concerns, and 3) streamlining the efficiency of the operating room (and thereby making surgeries more profitable).
Skyline Medical’s STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of Skyline Medical’s STREAMWAY System, the number of canisters can be significantly reduced. Skyline Medical Inc.’s STREAMWAY System is designed to make the operating room and our environment safer, cleaner, and better. Skyline Medical products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.skylinemedical.com.
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $3.4 million in debts, liabilities and cash obligations that predominantly become due in calendar 2015; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company’s financial position. See the Company’s most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.
Skyline Investor Relations Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203
SOURCE: Skyline Medical, Inc.